Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers. Omidubicel is a nicotinamide-modified...
9 KB (641 words) - 07:31, 30 June 2024
allogeneic cell therapies have been developed, Prochymal and Cartistem. Omidubicel was approved for medical use in the United States in April 2023. To limit...
73 KB (8,351 words) - 02:01, 21 July 2024